STAT+: How Trump’s funding cuts are reshaping the health system
Young startups miss out on biotech venture funding rebound, MassBio says
The restructuring comes after an unnamed "large pharmaceutical customer" terminated a contract with the company, Cellares CEO Fabian Gerlinghaus posted on LinkedIn. Read More
WASHINGTON — In the past three years, Robert F. Kennedy Jr. has had a dramatic ascent, rocketing from the contrarian fringe to the center of the American health...
The Food and Drug Administration approved on Thursday a gene therapy for severe leukocyte adhesion deficiency type 1 (LAD-1), an ultra-rare disease that leaves children vulnerable...
WASHINGTON — A motivational coach, a venture capitalist who worked with health secretary Robert F. Kennedy Jr.’s son, and a number of health care executives whose...
On this week’s episode of “The Readout LOUD”: Allison DeAngelis is still away, leaving Elaine Chen and Adam Feuerstein to mind the podcasting store. You’ve been warned....
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. The FDA granted accelerated approval...
A jury in Los Angeles has found social media giants Google and Meta liable for the mental health struggles of a 20-year-old woman, awarding her $3...
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your...
Scan to Read